| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.814 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 1.814 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 11.327 | 3.340 | 1.892 | 1.581 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | -9.513 | -3.340 | -1.892 | -1.581 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | -9.513 | -3.340 | -1.892 | -1.581 | 0 | 0 | 0 | 0 | 0 | - |
| Employees | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Biostarchim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 4.049 | 4.687 | 16 | 18 | 18 | 18 | 17 | 17 | 17 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Cash | 4.049 | 4.687 | 16 | 18 | 18 | 18 | 17 | 17 | 17 | - |
| Shareholders Funds | -24.737 | -27.825 | -29.246 | -30.290 | -29.703 | -29.140 | -28.494 | -28.582 | -28.496 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 28.786 | 32.512 | 29.262 | 30.308 | 29.721 | 29.158 | 28.511 | 28.600 | 28.513 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4675 - 4675" | |||||||||
| CAEN Financial Year |
4675
|
|||||||||
Comments - Biostarchim Srl